Pasireotide Diaspartate | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Pasireotide Diaspartate
US Patents

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

SPI Pharma has been solving formulation challenges using superior functional materials.

Contact Supplier

Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

Contact Supplier

Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

Contact Supplier

FAMAR CDMO- From early development to commercial manufacturing.

Contact Supplier

Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

Contact Supplier

Pasireotide Diaspartate

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

2 API Suppliers, 2 Listed Suppliers

2 API Suppliers
2 Listed Suppliers

FINISHED DOSAGE FORMULATIONS

6 FDF Dossiers, 3 FDA Orange Book, 3 Canada

6 FDF Dossiers
3 FDA Orange Book
3 Canada

DRUG PRODUCT COMPOSITIONS

SOLUTION;SUBCUTANEOUS - EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML), SOLUTION;SUBCUTANEOUS - EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML), SOLUTION;SUBCUTANEOUS - EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)

SOLUTION;SUBCUTANEOUS - EQ 0.3MG BASE/ML (EQ 0.3MG BASE/ML)
SOLUTION;SUBCUTANEOUS - EQ 0.6MG BASE/ML (EQ 0.6MG BASE/ML)
SOLUTION;SUBCUTANEOUS - EQ 0.9MG BASE/ML (EQ 0.9MG BASE/ML)

DIGITAL CONTENT

1 NEWS #PharmaBuzz

1 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

1 US Medicaid Prescriptions

1 US Medicaid Prescriptions

PATENTS & EXCLUSIVITIES

6 US Patents, 9 Health Canada Patents

6 US Patents
9 Health Canada Patents

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 6RECORDATI RARE

filter Patent Number Reset all filters

6 All

01 37473761

02 38299209

filter API Patent Reset all filters

6 All

01 6Y

filter FDF Patent Reset all filters

6 All

01 6Y

filter Expiration Date Reset all filters

6 All

01 32025-12-27

02 32026-12-14

Product Main Page

01

RECORDATI RARE

PASIREOTIDE DIASPARTATE

PharmScience R&D

Not Confirmed

RECORDATI RARE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-27

PASIREOTIDE DIASPARTATE

US Patent Number : 8299209

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-27

Product Web Link

Digital Content

Corporate PDF

02

RECORDATI RARE

PASIREOTIDE DIASPARTATE

PharmScience R&D

Not Confirmed

RECORDATI RARE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE DIASPARTATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Product Web Link

Digital Content

Corporate PDF

03

RECORDATI RARE

PASIREOTIDE DIASPARTATE

PharmScience R&D

Not Confirmed

RECORDATI RARE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-27

PASIREOTIDE DIASPARTATE

US Patent Number : 8299209

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-27

Product Web Link

Digital Content

Corporate PDF

04

RECORDATI RARE

PASIREOTIDE DIASPARTATE

PharmScience R&D

Not Confirmed

RECORDATI RARE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2025-12-27

PASIREOTIDE DIASPARTATE

US Patent Number : 8299209

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-12-27

Product Web Link

Digital Content

Corporate PDF

05

RECORDATI RARE

PASIREOTIDE DIASPARTATE

PharmScience R&D

Not Confirmed

RECORDATI RARE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE DIASPARTATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Product Web Link

Digital Content

Corporate PDF

06

RECORDATI RARE

PASIREOTIDE DIASPARTATE

PharmScience R&D

Not Confirmed

RECORDATI RARE

PharmScience R&D

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2026-12-14

PASIREOTIDE DIASPARTATE

US Patent Number : 7473761

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 200677

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2026-12-14

Product Web Link

Digital Content

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
ASK US!